Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
about
Neurodegeneration in multiple sclerosis: novel treatment strategiesMyelin damage and repair in pathologic CNS: challenges and prospectsOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionNutrition facts in multiple sclerosisOxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammationDiffusion fMRI detects white-matter dysfunction in mice with acute optic neuritisAxonal transport rate decreased at the onset of optic neuritis in EAE miceThe contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisIs mPTP the gatekeeper for necrosis, apoptosis, or both?Autophagy, inflammation and neurodegenerative disease.Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple SclerosisImpaired cerebrovascular reactivity in multiple sclerosisActivation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons.Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis.Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI.CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivityLocal translation of extranuclear lamin B promotes axon maintenanceGenetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophyTranslocator protein 18 kDa (TSPO) expression in multiple sclerosis patientsGanglion cell loss in relation to visual disability in multiple sclerosis.PATHOLOGIES OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASESDimethyl fumarate may still have a role in progressive multiple sclerosis.White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisWhat can we learn about stroke from retinal ischemia models?Mitochondrial channels: ion fluxes and more.Remyelination and multiple sclerosis: therapeutic approaches and challenges.Remyelinating strategies in multiple sclerosis.Targeting mitochondrial function to protect against vision loss.Secondary Progressive Multiple Sclerosis: Definition and Measurement.SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.Causal Effect of Genetic Variants Associated With Body Mass Index on Multiple Sclerosis Susceptibility.Modulating inflammation and neuroprotection in multiple sclerosis.Retinal Findings on OCT in Systemic Conditions.Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies.Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat.
P2860
Q22241472-B6E24EE4-C0FD-46A3-8420-A0268C0B1F32Q26797407-43882CE5-5450-47AB-81F5-2C75AD4182C1Q26822611-57E4648D-3CEE-4F7A-B9E0-64C66E129FE3Q26851247-C72EBAAD-2CEC-46CA-8D71-C05A70E2E209Q28486241-F96D23C0-D8F1-4C26-8038-3A8D7FEB468BQ30778741-62CF2AF0-2F17-4D4A-9F1B-5C7385446633Q34066839-FABDF314-144F-43A3-B42F-87EAD98335B8Q34413247-41DE9AE8-6E63-404A-8FF3-ED9E23508984Q34630758-F2D76DC2-6A94-496B-8256-7474D4E1B2E0Q34686890-E8DF886D-3F2A-49F5-B7C1-907E4708017CQ35009543-CC1AEC2A-2E79-4080-95B5-6A8D0F37B17DQ35094371-EEEC1728-1DBB-4EDD-82FA-CD4453AEFECEQ35222988-44CB8430-532C-4BD1-ACEC-5B5941811EECQ35245867-21E29371-2E8B-4D02-8172-62BFA54BB4C0Q35669169-F522BEBA-8F8C-44F6-8842-A5600D08B7CAQ35757295-841A0DBA-6621-43D5-A80F-953929B4E189Q35800537-D4703E76-5DC0-4AD5-B9F0-E37451FF7E07Q35834510-21B524E5-C9A7-4079-995D-063578104C6EQ35859533-D495EC60-E925-4A68-8B5D-68B01046F2AAQ36106275-FBE2CA01-316D-46E9-BD72-6A04454E6B47Q36376697-9088B356-BD98-4FE1-820C-F55AD9C74129Q36474703-6F86E753-6F9C-444D-977A-2CD106C0CA82Q36614273-39BBB40F-45D8-40B1-938B-447D53A46898Q36781704-1028B20D-5F14-490D-A8C8-EA0E64B6292DQ36907760-531A1217-A513-4E96-893E-88905E218DDDQ37027689-97971A32-D6D5-4388-94A7-6C94B0B8D562Q37972980-CE8E7319-5729-444D-8972-75AE9B033025Q38064307-B14709F5-E1FC-4ED8-B348-C0FC7FF1C044Q38201407-91C15585-6862-4476-8C5D-E865263296BAQ38238466-5356F7B5-EF6F-454E-86D9-6668EFA15517Q38261543-9234B415-9675-41BF-90BA-653EDD1F459CQ38694794-2D263F67-0D12-4670-B1CE-AC7CE384A2DBQ38831720-564DB9E9-F5AA-4DBE-864F-EED2B72E8544Q38913236-7A4315E5-438E-4EAF-A0F5-662628524819Q39028478-BB2661C3-ADA5-46E7-8EBE-D394ACC2BFC1Q39350409-858C731B-270A-4CC1-A99D-4C64D5497852Q39391134-1478C4F6-62F9-43C5-8612-289F595C8274Q39473471-BFF21A2E-581F-4D4F-8941-6D6438BA327FQ41136886-8F92167D-5E1D-4253-912E-4FB08C3D2BBEQ41833999-AE93B5F6-6686-45FB-B17E-371A9125FE97
P2860
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@en
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@nl
type
label
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@en
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@nl
prefLabel
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@en
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@nl
P2093
P2860
P1476
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
@en
P2093
Dennis Bourdette
Gary Banker
Kimmy G Su
Michael Forte
P2860
P2888
P304
P356
10.1007/S11910-009-0060-3
P577
2009-09-01T00:00:00Z